On the Record with Robbins Geller

First Quarter 2017

Robbins Geller’s excellent track record continued for the first quarter of 2017. The Firm remains dedicated to protecting the rights of defrauded investors and consumers, and recent results illustrate that commitment. In January, after more than five years of litigation, the Firm achieved unprecedented corporate governance reforms in Community Health Systems.  The settlement in that case yielded a $60 million cash payment and corporate governance reforms that include two shareholder-nominated directors, the creation of a Healthcare Law Compliance Coordinator, the implementation of an automatic compensation clawback provision, the establishment of an insider trading controls committee, and the adoption of a political expenditure disclosure policy.

Once again, the Firm’s mergers and acquisitions practice stood out, as Robbins Geller obtained the two largest post-merger common fund settlements in California state court history (Onyx Pharmaceuticals – $30 million and Websense, Inc. – $40 million).  Additionally, Robbins Geller won the appeal in the United States Court of Appeals for the Eighth Circuit in the Medtronic securities class action.

Recognized by the courts and professional organizations, Robbins Geller was selected by The National Law Journal as one of the nation’s Elite Trial Lawyers for the third consecutive year. The publication also named the Firm the Securities category winner for 2016 out of 35 finalists. Law360 named the Firm one of the nation’s top Securities Practice Groups of the Year for 2016, and not only did Benchmark Litigation name Robbins Geller one of the Top 10 Plaintiff Firms in America, the publication also selected the Firm as a “Highly Recommended” plaintiffs firm for 2017.  Most recently, just after publication, Institutional Shareholder Services (“ISS”) ranked Robbins Geller first among all securities class action firms in its SCAS Top 50 Report for the third consecutive year. ISS found that in 2016, the Firm recovered more than $2.7 billion for investors, $730 million more than any other firm.

Robbins Geller looks forward to many more successes on behalf of its clients throughout 2017.

Read More Firm News

Main Menu